Seeking Simpler Solutions with Diabetes Technology
Abstract
This editorial discusses the evolution of diabetes technology, focusing on automated insulin-delivery systems (closed-loop systems) designed to improve glycemic control in type 1 diabetes. It highlights the results of a trial by Russell et al., which demonstrated the efficacy of the iLet bionic pancreas a simplified system requiring only body weight input and qualitative meal announcements. The editorial emphasizes the potential of such technologies to democratize access to advanced diabetes care, particularly for patients with limited numeracy skills or those relying on primary care providers. It also calls for broader insurance coverage and equitable access to these innovations to reduce disparities in diabetes outcomes.